BioCentury
ARTICLE | Financial News

Seattle Genetics raises $30 million

March 14, 2000 8:00 AM UTC

Bank of America Ventures led the venture financing, which will help fund the company's clinical trials of monoclonal antibodies for cancer. Other investors included Cascade Investment; Vulcan Ventures...